About Luke
Luke Jedynak is a partner in the firm’s corporate and commercial team. He is a trusted adviser to a broad portfolio of commercial clients, including ASX 100 companies, private equity firms, and large privately-held businesses.
Luke provides strategic counsel on a diverse range of commercial matters, including large-scale mergers and acquisitions and special situations as well as smaller, targeted investments. His expertise frequently extends to clients with international interests seeking to invest in Australia.
Recognised for his sharp, commercial acumen and outcomes-driven approach, Luke is consistently regarded as an indispensable partner, helping clients navigate their legal and business challenges to achieve long-term success.
Previously, Luke was a senior advisor to the Commonwealth Treasurer, the Hon Josh Frydenberg, with responsibility for corporate law related matters. In his role, Luke worked closely with senior executives within the Commonwealth Treasury and collaborated with key federal regulators, including the Australian Securities & Investments Commission, the Australian Competition & Consumer Commission and Australia’s Foreign Investment Review Board.
Practice focus
Luke’s practice focuses on the following areas:
- mergers and acquisitions, in particular private share and asset sales
- capital raisings, in particular private capital raisings
- strategic investments, including early-stage investments
- joint ventures, including shareholder agreements
- foreign investment review board advice, and
- general commercial and corporate advice.
Experience
Luke has advised on a range of matters, including:
- Acted for specialist radiology clinic and diagnostic imaging provider DiagnostiCare on its sale to Imaging Associates Group, which is owned by Advent Partners
- Acted for the shareholders of “Buy Sell Move” on the sale of their supply chain management software business to WiseTech Global
- Regularly act for ForHealth, which is Australia’s largest GP practice management business and owned by BGH, on its bolt-on acquisition of GP clinics and other medical businesses
- Acted as Australian counsel for the new major equity owners of GenesisCare, one of Australia’s largest providers of cancer services, in connection with a debt-for-equity swap as part of GenesisCare’s US$2.1 billion restructure
-
Strategic investment by Macquarie Capital Principal Finance, a division of Macquarie Bank, in Envest, the Australian based insurance investment and distribution business of the Ardonagh Group, giving Macquarie a 15% interest and Envest an enterprise value of more than A$1 billion
- Acted for Australian legal technology provider Atticus on its series A capital raise
-
Sale by European private equity firm JAB to EQT Group of VetPartners, Australia and New Zealand’s largest provider of veterinary and animal health services
-
Sale by Apotex International of its 50% interest in Arrotex, Australia’s largest generic pharmaceutical company
- The A$1.35 billion sale by 26 Australian industry super funds of ME Bank to Bank of Queensland Ltd
- Nufarm’s divestment of its Latin American business to Sumitomo Chemical for A$1.18 billion
- Sale of RYCO Hydraulics by its CEO and major shareholder to Italian based Manuli Rubber Industries
- The merger of Apotex Australia and Arrow Pharmaceuticals to form Australia’s largest generic pharmaceuticals company
- Acting for the minority shareholders of Australian wagering company BetEasy in relation to the sale of their remaining interest in BetEasy to Canadian gaming company The Stars Group and Stars’ subsequent merger with Irish bookmaker Flutter Entertainment plc, and
- Acting for Krispy Kreme Doughnut Corporation in relation to its acquisition of the Krispy Kreme Australia and New Zealand franchise business from its founding shareholders.
Awards & recognition
Luke was recognised in 2025/26 Best Lawyers® International Guide as ‘One to watch’ in corporate law.
